Dr Nadeem Ali has explained what could be behind a sudden change ...

A 65-year-old white woman presented with 9 months of intermittent “kaleidoscopic” visual disturbances and blurred vision upon awakening.Her medical history was significant for hypertension, ...

Computed tomography angiography of the head and neck (CTAHN) is most likely to reveal an acute finding that changes emergency management in patients presenting with suspected stroke, especially when ...

Argenx delivered Q4 2025 product net sales of $1.3B and $4.2B for the full year, up 90% year over year as VYVGART demand accelerated globally. The company reported Q4 operating profit of $367M and ...

SE has achieved rapid commercial success with VYVGART, driving $4.2 billion in 2025 sales and operational profitability. Learn more about ARGX stock here.

Maggie Aime has over 25 years of experience in healthcare and as a nurse across specialties including oncology, kidney transplant, cardiology, and more. She leverages her rich healthcare experience to ...

Positive results from Phase 3 ADAPT OCULUS study show VYVGART’s potential as the first targeted treatment for patients ...

If conscription ever did come back into force, there are certain health conditions that would render people exempt.

New DVLA digital driving licence system will be unveiled in April.

Drivers must understand the nature of not disclosing medical conditions to the DVLA ...